Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean population.

Neuropsychobiology - 1 Jan 2004

Pae Chi-Un, Kim Jung-Jin, Yu Hye-Sook, Lee Chang-Uk, Lee Soo-Jung, Jun Tae-Youn, Lee Chul, Paik In-Ho

Abstract excerpt

The aim of this study was to investigate the association between monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism and DSM-IV-based bipolar I disorder (BID) in Korea. Ninety-two patients with BID and 114 healthy controls participated in this study. A polymerase chain reaction-based method was used for genotyping. Genotype and allele distributions in patients with BID were not different from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bipolar Disorder
Share to Chemokine CCL2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chi-Square Distribution

Share to Diagnostic and Statistical Manual of Mental Disorders

Share to Genetic Heterogeneity

Share to Promoter Regions, Genetic

Share to Reverse Transcriptase Polymerase Chain Reaction

Source

Identifiers

PMID: 15034225
DOI: 10.1159/000076718

Genes

BID

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monocyte chemoattractant protein-1 promoter -2518 polymorphism may have an influence on clinical heterogeneity of bipolar I disorder in the Korean population.PMID 15034225Read ↗

No association of the MCP-1 promoter A-2518G polymorphism with bipolar disorder in the Korean population.Semantic proximity Read ↗

Monocyte chemoattractant protein-1 (MCP1) promoter -2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population.Semantic proximity Read ↗

A Study on the Association of Interleukin-1 Cluster with Genetic Risk in Bipolar I Disorder in Iranian Patients: A Case-control Study.Semantic proximity Read ↗

Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.Semantic proximity Read ↗

DAOA variants on diagnosis and response to treatment in patients with major depressive disorder and bipolar disorder.Semantic proximity Read ↗

Evaluation of paraoxonase 1 polymorphisms in patients with bipolar disorder.Semantic proximity Read ↗

Tumor necrosis factor-beta gene polymorphism may not be associated with major depressive disorder in the Korean population.Semantic proximity Read ↗

Monocyte chemoattractant protein-1 levels are associated with major depressive disorderSemantic proximity Read ↗

Gender-specific association of the SLC6A4 and DRD2 gene variants in bipolar disorder.Semantic proximity Read ↗

The interaction between BDNF and DRD2 in bipolar II disorder but not in bipolar I disorder.Semantic proximity Read ↗

BanI polymorphism of the cytosolic phospholipase A2 gene and mood disorders in the Korean population.Semantic proximity Read ↗

The serotonin transporter (5-HTTLPR) but not serotonin receptor (5-HT2C Cys23Ser) variant is associated with bipolar I disorder in Kurdish population from Western Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.